reference/18836418

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18836418

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Extramural
endingPage	593
issn	1365-182X
issueIdentifier	7
pageRange	587-593
publicationName	HPB : the official journal of the International Hepato Pancreato Biliary Association
startingPage	587
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_705e23672e9a02d170250ecfd98c7869 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_47b82c0b9fd0c53483463fb1eb08a678 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_33228905021516c9e815e5473cab1934 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dd22e41f38fff519928832c2ac459336 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ebfd5ffe4ecf238f8d6c5e45d06d4512
bibliographicCitation	Cho M, Wang-Gillam A, Myerson R, Gao F, Strasberg S, Picus J, Sorscher S, Fournier C, Nagaraj G, Parikh P, Suresh R, Linehan D, Tan BR. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. HPB (Oxford). 2015 Jul;17(7):587–93. PMID: 25800066; PMCID: PMC4474505.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3db7026050e4a5ae60e4db1f176506f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1425-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1912c7ef6d7d5e5e5da61895a838e166 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb4e9f2d8ac54569147bf64fae41f32a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44cca281cd0edf3c554b7fd1edd400ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_845b29ba3cad01843182bc5669c1ed06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81d0547f5272fc5e6374900a925defd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c191c96cbe4a531edce93d7eb2c63cb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18a7fba6800a91e68b0c205468f0b783 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f953f7d04ae62ebe5762bfdcf90ee53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08f74fdfb9528906fa37c43c880e118d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7586-6920 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96a325529401bcb30f2d8a14b9cf034c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e4b02f318597da13cc19de3da988572 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9973e706cda8492572f13dcb1f642ec5
date	201507
identifier	https://pubmed.ncbi.nlm.nih.gov/25800066 https://doi.org/10.1111/hpb.12413 https://pubmed.ncbi.nlm.nih.gov/PMC4474505
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33398 https://portal.issn.org/resource/ISSN/1365-182X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M000754277
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D001662Q000009 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D001662Q000401 http://id.nlm.nih.gov/mesh/D059186Q000401 http://id.nlm.nih.gov/mesh/D002277Q000628 http://id.nlm.nih.gov/mesh/D001661Q000628 http://id.nlm.nih.gov/mesh/D059186Q000009 http://id.nlm.nih.gov/mesh/D010190Q000628 http://id.nlm.nih.gov/mesh/D010180Q000009 http://id.nlm.nih.gov/mesh/D010180Q000401
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003841Q000009 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D043823Q000009 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D001661Q000401 http://id.nlm.nih.gov/mesh/D002277Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D002277Q000401 http://id.nlm.nih.gov/mesh/D010190Q000473 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001661Q000473 http://id.nlm.nih.gov/mesh/D005240 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D010190Q000401
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7039 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385

Showing number of triples: 1 to 90 of 90.